FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC ...Middle East

Medscape - News
The US Food and Drug Administration has granted accelerated approval for tepotinib for the treatment of adults with metastatic non–small cell lung cancer harboring MET exon 14 skipping alterations. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News